Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00257920 · ClinicalTrials.gov registry record · Phase 4
A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease
A Phase 4 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT00257920 is a Phase 4 study that has completed, run by Abbott. The registered enrollment target is 41 participants.
The verdict
NCT00257920, a Phase 4 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of Zemplar® Injection and Hectorol® Injection on intestinal calcium absorption in Chronic Kidney Disease Stage 5 subjects on hemodialysis.
Interventions
- DRUG Zemplar® injection
- DRUG Hectorol® injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2006-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00257920
The ClinicalTrials.gov registry entry for NCT00257920 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Zemplar® injection is the first listed.
NCT00257920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00257920 about?
NCT00257920 is a clinical study titled "A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease". The purpose of this study is to evaluate the effects of Zemplar® Injection and Hectorol® Injection on intestinal calcium absorption in Chronic Kidney Disease Stage 5 subjects on hemodialysis.
What is the current status of trial NCT00257920?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2006-06.
What interventions are being tested in trial NCT00257920?
The interventions under investigation include: Zemplar® injection (DRUG), Hectorol® injection (DRUG).
Who is sponsoring clinical trial NCT00257920?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.